HIFs (Hypoxia-inducible factors) are transcription factors that respond to changes in available oxygen in the cellular environment, to be specific, to decreases in oxygen, or hypoxia. The HIF signaling cascade mediates the effects of hypoxia, the state of low oxygen concentration, on the cell. Hypoxia often keeps cells from differentiating. However, hypoxia promotes the formation of blood vessels, and is important for the formation of a vascular system in embryos, and cancer tumors. The hypoxia in wounds also promotes the migration of keratinocytes and the restoration of the epithelium. In general, HIFs are vital to development. In mammals, deletion of the HIF-1 genes results in perinatal death. HIF-1 has been shown to be vital to chondrocyte survival, allowing the cells to adapt to low-oxygen conditions within the growth plates of bones. HIF plays a central role in the regulation of human metabolism. Recently, several drugs that act as selective HIF prolyl-hydroxylase inhibitors have been developed.
HATC 是一种 HIF-1α AUTAC 降解剂,可将 HIF-1α 与 LC3 连接形成三元复合物,经自噬-溶酶体融合途径降解,从而在多种细胞类型中诱导剂量依赖性的 HIF-1α 降解,并可降低内脏脂肪堆积、肝脏脂质沉积、衰老细胞聚集和骨丢失,缓解年龄相关性椎间盘退变、肝功能异常、脊柱后凸及肺泡扩张,降低循环乳酸水平,改善体能,逆转年龄相关性粒细胞比例变化,延长中位寿命与最长寿命,降低转录组学年龄,且无明显的持续性毒性,可用于年龄相关性疾病的研究 (粉色:LC3 配体 (MS-P29952);蓝色:HIF-1α 配体 (MS-L37264);Linker:)。
NEO-811 是一种选择性口服活性 ARNT (HIF-1β) 分子胶降解剂,通过 CRL4-CRBN E3 连接酶介导 ARNT 降解,可用于透明细胞肾细胞癌 (ccRCC) 的研究。
PROTAC HIF-1α degrader-1(compound V2)是一种有效的缺氧诱导因子-1α(hypoxia-inducible factor-1α,HIF-1α)PROTAC 降解剂,IC50 值为 7.54 µM,具有抗增殖活性,可降低 HIF-1α 蛋白表达并诱导细胞凋亡(apoptosis)(粉色:HIF-1α 配体 (MS-A03266);蓝色:VHL 配体 (MS-R95960);黑色:连接子 (MS-S10954))。
PROTAC HIF-1α degrader-2 是一种高效且选择性的靶向 HIF-1α 的 PROTAC 降解剂,通过促进 HIF-1α/VHL 三元复合物的形成并经泛素-蛋白酶体途径促进 HIF-1α 降解,可抑制 HeLa 细胞的增殖、迁移和克隆形成并诱导细胞凋亡 (apoptosis),还可降低 MAPK 和 PI3K/AKT 通路中 p-MEK 和 p-AKT 的表达,因此可用于宫颈癌的研究(粉色:HIF-1α 配体 (MS-P45854);蓝色:VHL 配体 (MS-L68940);黑色:连接子)。
SH-26 是一种 PHD1 PROTAC 降解剂,在 MDA-MB-231、HepG2 和 HEK-293T 细胞中对 PHD1 的 DC50 值分别为 1.06 μM、4.16 μM 和 4.91 μM,它可招募 CRBN 并通过泛素-蛋白酶体系统诱导 PHD1 降解,还能减轻 APAP (MS-H20928) 引发的活性氧 (ROS) 蓄积、线粒体功能障碍及 NLRP3 炎症小体激活,可用于急性肝损伤相关研究(粉色:HIF/HIF Prolyl-Hydroxylase 配体 (MS-H38708);蓝色:Cereblon 配体 (MS-Q68284);黑色:连接子)。
Pseudolaric Acid B 是一种口服有效的二萜酸,具有抗真菌、抗生育、抗血管生成和抗癌活性,可诱导肿瘤细胞凋亡 (apoptosis) 和自噬 (autophagy),并可抑制乙肝病毒 (HBV) 分泌,同时具有免疫抑制作用,能选择性抑制 T 淋巴细胞增殖和 IL-2 产生。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号